Abstract

The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2022 annual
Dr. Kristen Dams-O'Connor has made remarkable contributions to the Journal of Neurotrauma and to the field of traumatic brain injury as a whole. She has been among the journal's most prolific authors, leading or contributing to six papers submitted or published in 2022:
Alzheimer's Disease-Related Dementias Summit 2022: National Research Priorities for the Investigation of Post-Traumatic Brain Injury Alzheimer's Disease and Related Dementias
Screening for Brain Injury Sustained in the Context of Intimate Partner Violence: Measure Development and Preliminary Utility of the Brain Injury Screening Questionnaire IPV Module
Associations of Military Service History and Health Outcomes in the First Five Years After Traumatic Brain Injury
Association Between the Attention Network Test, Neuropsychological Measures, and Disability in Post-Acute Traumatic Brain Injury
International Survey of Antiseizure Medication Use in Patients with Complicated Mild Traumatic Brain Injury: A New York Neurotrauma Consortium Study
Long-Term Effects of Repeated Blast Exposure in United States Special Operations Forces Personnel: A Pilot Study Protocol
In addition, she has been an excellent reviewer for the journal and a vigorous participant in scientific discussions in the field.
Biosketch
Kristen Dams-O'Connor, PhD, is the Jack Nash professor and vice chair of research in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai in New York, where she serves as director of the Brain Injury Research Center of Mount Sinai. Her multidisciplinary research program aims to identify mechanisms, risk, and protective factors to improve long-term outcomes in individuals with traumatic brain injury (TBI) among civilians, military service members, and survivors of partner violence. She leads the Late Effects of TBI (LETBI) project, a longitudinal prospective TBI brain donor program that aims to characterize the clinical phenotype and postmortem pathological signatures of posttraumatic neurodegeneration. Her team uses modern psychometric and statistical techniques to measure individual differences in change over time following TBI. Dr. Dams-O'Connor leads the Department of Defense–funded ENRICH brain health study designed to uncover mechanistic contributors to post-TBI cognitive and psychological health decline. She is project director of the New York Traumatic Brain Injury Model System of Care, one of 16 centers of excellence for TBI research and clinical care in the United States.
